Annual CFO:
-$166.31M-$85.14M(-104.89%)Summary
- As of today, MLYS annual cash from operations is -$166.31 million, with the most recent change of -$85.14 million (-104.89%) on December 31, 2024.
- During the last 3 years, MLYS annual cash from operations has fallen by -$151.75 million (-1042.34%).
- MLYS annual cash from operations is now -6652.50% below its all-time high of -$2.46 million, reached on December 1, 2020.
Performance
MLYS Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFO:
-$30.17M+$15.32M(+33.68%)Summary
- As of today, MLYS quarterly cash from operations is -$30.17 million, with the most recent change of +$15.32 million (+33.68%) on June 30, 2025.
- Over the past year, MLYS quarterly cash from operations has dropped by -$23.00 thousand (-0.08%).
- MLYS quarterly cash from operations is now -451.64% below its all-time high of -$5.47 million, reached on June 1, 2022.
Performance
MLYS Quarterly Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$192.69M-$23.00K(-0.01%)Summary
- As of today, MLYS TTM cash from operations is -$192.69 million, with the most recent change of -$23.00 thousand (-0.01%) on June 30, 2025.
- Over the past year, MLYS TTM cash from operations has dropped by -$95.39 million (-98.04%).
- MLYS TTM cash from operations is now -3423.22% below its all-time high of -$5.47 million, reached on June 1, 2022.
Performance
MLYS TTM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
MLYS Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -104.9% | -0.1% | -98.0% |
| 3Y3 Years | -1042.3% | -451.6% | -3423.2% |
| 5Y5 Years | -6652.5% | - | - |
MLYS Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -1042.3% | at low | -331.7% | +54.9% | -1446.8% | at low |
| 5Y | 5-Year | -6652.5% | at low | -451.6% | +54.9% | -3423.2% | at low |
| All-Time | All-Time | -6652.5% | at low | -451.6% | +54.9% | -3423.2% | at low |
MLYS Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$30.17M(+33.7%) | -$192.69M(-0.0%) |
| Mar 2025 | - | -$45.49M(+31.9%) | -$192.66M(-15.8%) |
| Dec 2024 | -$166.31M(-104.9%) | -$66.84M(-33.2%) | -$166.31M(-29.5%) |
| Sep 2024 | - | -$50.19M(-66.5%) | -$128.45M(-32.0%) |
| Jun 2024 | - | -$30.15M(-57.5%) | -$97.30M(-11.1%) |
| Mar 2024 | - | -$19.14M(+34.0%) | -$87.54M(-7.8%) |
| Dec 2023 | -$81.17M | -$28.98M(-52.3%) | -$81.17M(-30.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$19.03M(+6.6%) | -$62.38M(-23.9%) |
| Jun 2023 | - | -$20.39M(-59.6%) | -$50.34M(-42.1%) |
| Mar 2023 | - | -$12.78M(-25.4%) | -$35.42M(-56.4%) |
| Dec 2022 | -$29.22M(-100.7%) | -$10.19M(-45.8%) | -$22.64M(-81.8%) |
| Sep 2022 | - | -$6.99M(-27.8%) | -$12.46M(-127.8%) |
| Jun 2022 | - | -$5.47M | -$5.47M |
| Dec 2021 | -$14.56M(-491.1%) | - | - |
| Dec 2020 | -$2.46M | - | - |
FAQ
- What is Mineralys Therapeutics, Inc. annual cash from operations?
- What is the all-time high annual cash from operations for Mineralys Therapeutics, Inc.?
- What is Mineralys Therapeutics, Inc. annual cash from operations year-on-year change?
- What is Mineralys Therapeutics, Inc. quarterly cash from operations?
- What is the all-time high quarterly cash from operations for Mineralys Therapeutics, Inc.?
- What is Mineralys Therapeutics, Inc. quarterly cash from operations year-on-year change?
- What is Mineralys Therapeutics, Inc. TTM cash from operations?
- What is the all-time high TTM cash from operations for Mineralys Therapeutics, Inc.?
- What is Mineralys Therapeutics, Inc. TTM cash from operations year-on-year change?
What is Mineralys Therapeutics, Inc. annual cash from operations?
The current annual cash from operations of MLYS is -$166.31M
What is the all-time high annual cash from operations for Mineralys Therapeutics, Inc.?
Mineralys Therapeutics, Inc. all-time high annual cash from operations is -$2.46M
What is Mineralys Therapeutics, Inc. annual cash from operations year-on-year change?
Over the past year, MLYS annual cash from operations has changed by -$85.14M (-104.89%)
What is Mineralys Therapeutics, Inc. quarterly cash from operations?
The current quarterly cash from operations of MLYS is -$30.17M
What is the all-time high quarterly cash from operations for Mineralys Therapeutics, Inc.?
Mineralys Therapeutics, Inc. all-time high quarterly cash from operations is -$5.47M
What is Mineralys Therapeutics, Inc. quarterly cash from operations year-on-year change?
Over the past year, MLYS quarterly cash from operations has changed by -$23.00K (-0.08%)
What is Mineralys Therapeutics, Inc. TTM cash from operations?
The current TTM cash from operations of MLYS is -$192.69M
What is the all-time high TTM cash from operations for Mineralys Therapeutics, Inc.?
Mineralys Therapeutics, Inc. all-time high TTM cash from operations is -$5.47M
What is Mineralys Therapeutics, Inc. TTM cash from operations year-on-year change?
Over the past year, MLYS TTM cash from operations has changed by -$95.39M (-98.04%)